Feed Symbols: EMN

Keybanc analyst Aleksey Yefremov maintains Eastman Chemical (NYSE:EMN) with a Overweight and raises the price target from $124 to $125.

Within the last quarter, Eastman Chemical (NYSE:EMN) has observed the following analyst ratings:

UBS analyst Joshua Spector maintains Eastman Chemical (NYSE:EMN) with a Buy and lowers the price target from $121 to $118.

Eastman Chemical (NYSE:EMN) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Eastman Chemical beat estimated earnings by 5.2%, reporting an EPS of $2.83 versus an estimate of $2.69.

Eastman Chemical (NYSE:EMN) reported quarterly earnings of $2.83 per share which beat the analyst consensus estimate of $2.69 by 5.2 percent. This is a 15.04 percent increase over earnings of $2.46 per share from the

Eastman Chemical Company (NYSE: EMN) is set to release second-quarter 2022 results after the closing bell on Jul 28.

Keybanc analyst Aleksey Yefremov maintains Eastman Chemical (NYSE:EMN) with a Overweight and lowers the price target from $142 to $124.

Over the past 3 months, 8 analysts have published their opinion on Eastman Chemical (NYSE:EMN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

B of A Securities analyst Matthew DeYoe maintains Eastman Chemical (NYSE:EMN) with a Neutral and lowers the price target from $123 to $115.

Analysts have provided the following ratings for Eastman Chemical (NYSE:EMN) within the last quarter: